Paula Stafford

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

BioClinica, Inc. engages in the provision of integrated and technology-enhanced clinical trial management services. It offers research network, eclinical solutions, randomization and trial supply management, medical imaging, and cardiac safety. The company was founded in 1990 and is headquartered in Princeton, NJ.

IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT.

PPC Investment Partners LP (PPC Investment Partners) is a private equity firm founded in 2002 by Tony N. Pritzker and Jay Robert Pritzker. The firm is headquartered in Chicago, Illinois.

Health Decisions, Inc. engages in conducting research in clinical development of drugs, diagnostics, medical devices for advancement of women's health. It offers trial management, monitoring, data and quality management, biostatistics, study design and protocol development and consulting services. The company is headquartered in Durham, NC.

IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC.

Cenduit LLC provides clinical supply chain intelligence, operations management and technology services. It offers drug accountability, custom reporting, and eClinical integration services. The company was founded in May 2007 and is headquartered in Durham, NC.

Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021.